Reversal of hyperactive Wnt signaling-dependent adipocyte defects by peptide boronic acids

Tianyi Zhang1, Fu-Ning Hsu2, Xiao-Jun Xie2

  • 1Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637.

Insights

Researchers found that peptide boronic acids can mitigate Wnt signaling and adipocyte defects in a Drosophila model. This modulation of beta-catenin activity via alpha-catenin offers a novel therapeutic strategy for related diseases.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Pharmacology

Background:

  • Aberrant Wnt signaling and lipid metabolism are implicated in obesity, diabetes, and cancer.
  • Identifying therapeutic targets that modulate these pathways is crucial.

Purpose of the Study:

  • To establish a Drosophila model of hyperactivated Wnt signaling.
  • To identify pharmacologic agents that can mitigate Wnt signaling and associated phenotypes.
  • To elucidate the mechanism of action for identified inhibitors.

Main Methods:

  • Established a Drosophila model with hyperactivated Wnt signaling due to partial loss of axin.
  • Screened for pharmacologic agents capable of rescuing phenotypes in Axin mutants.
  • Investigated the role of alpha-catenin in mediating the effects of peptide boronic acids.

Main Results:

  • Axin mutant larvae exhibited transparency and severe adipocyte defects due to upregulated beta-catenin.
  • Bortezomib and peptide boronic acids were identified as effective in mitigating these phenotypes.
  • The suppressive effect of peptide boronic acids on Wnt signaling was dependent on alpha-catenin.

Conclusions:

  • Pharmacologic modulation of beta-catenin activity through alpha-catenin is a viable strategy for attenuating Wnt signaling in vivo.
  • This approach offers a potential therapeutic avenue for diseases associated with Wnt pathway dysregulation and metabolic disorders.